Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention
- 1 February 2002
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 89 (4) , 372-376
- https://doi.org/10.1016/s0002-9149(01)02254-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantationJournal of the American College of Cardiology, 2001
- Early and long-term results of stenting of diffuse coronary artery diseaseThe American Journal of Cardiology, 2000
- Interleukin-1 Receptor Antagonist Expression in Human Endothelial Cells and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Direct Evidence for Cytokine Involvement in Neointimal HyperplasiaCirculation, 2000
- Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantationThe American Journal of Cardiology, 2000
- Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplastyJournal of the American College of Cardiology, 1999
- Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable anginaThe American Journal of Cardiology, 1998
- The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications.Journal of Clinical Investigation, 1997
- Interleukin-1 receptor antagonist circulates in experimental inflammation and in human diseaseBlood, 1992
- Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.Journal of Clinical Investigation, 1991